A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

1. Rugo, H.S.
2. Trédan, O.
3. Ro, J.
4. Morales, S.M.
5. Campone, M.
6. Musolino, A.
7. Afonso, N.
8. Ferreira, M.
9. Park, K.H.
10. Cortes, J.
11. Tan, A.R.
12. Blum, J.L.
13. Eaton, L.
14. Gause, C.K.
15. Wang, Z.
16. Im, E.
17. Mauro, D.J.
18. Jones, M.B.
19. Denker, A.
20. Baselga, J.